GeniqueCARE DCVD

What it covers

Genetic risk profiling for type-2 diabetes, cardiovascular disease and other complex conditions such as Alzheimer's.

What you get

A clear read on inherited risk that supports early lifestyle interventions.

Who it's for

People with a family history of chronic illness, and clinicians planning preventive care.

From sample to report

Sequenced in an accredited lab and returned as a counsellor-reviewed report framed around choices, not verdicts.

What the panel reads

DCVD profiles genetic predisposition to two of the most common multifactorial conditions, type 2 diabetes and cardiovascular disease, so risk can be understood and managed early rather than diagnosed late.

The clinical panel that pairs with it

Genetic predisposition is a baseline, not a diagnosis, so each report is designed to be read alongside current biochemistry. The pairing differs by which risk the report surfaces.

• Cardiovascular predisposition: liver and kidney function tests, lipid profile, HbA1c, fasting and post-prandial sugar, vitamin D, and insulin.
• Diabetes predisposition: insulin, fasting and post-prandial sugar, ketone, HbA1c, lipid profile, and liver and kidney function tests.

How a result is expressed

Every trait resolves to one of four zones rather than a raw score, because a number without a scale tells you nothing. A higher zone reflects genetic tendency, not a diagnosis.

• Low: below-average tendency.
• Average: typical population tendency.
• Elevated: above-average, worth monitoring.
• High: notably high, worth acting on early.